10
POPS"Miracle Cure For Alzheimer's Disease?"
continues: The new study documents a dramatic and unprecedented therapeutic effect in an Alzheimer's patient: improvement within minutes following delivery of perispinal etanercept, which is etanercept given by injection in the spine. Etanercept (trade name Enbrel) binds and inactivates excess TNF. Etanercept is FDA approved to treat a number of immune-mediated disorders and is used off label in the study. Griffin and Mark are pioneers in the field of neuroinflammation. Griffin published a landmark study in 1989 describing the association of cytokine overexpression in the brain and Alzheimer's disease. "It is unprecedented that we can see cognitive and behavioral improvement in a patient with established dementia within minutes of therapeutic intervention," said Griffin. "It is imperative that the medical and scientific communities immediately undertake to further investigate and characterize the physiologic mechanisms involved. This gives all of us in Alzheimer's research a tre
1
POPSFDA Looking Into Safety of RA Drugs TNF blockers like Remicade, Enbrel, Humira, and Cimzia are big sellers for drug companies. The FDA's investigation is preliminary -- part of the agency's effort to let consumers know about potential problems earlier. This was partly a response to the Avandia controversy. Click the link for the FDA's Early Communication.
2
POPSEx-Reps Say Amgen Used Patient Records Psoriasis is a skin condition where there is excessive skin production, and inflammation. It is not contagious, and while it's cause is not known it is believed to have a genetic component. The Drug being pushed by biotech company Amgen, is a genetically engineered injected drug known as Enbrel, that is known to have severe side effects. It is only approved for use in extreme cases of psoriasis.
2
Pops
Newest Clips
Latest Comments
Most Pops
Print
Save
Turn on live update